1Shirasaka T. New oral anticancer drug, ( TS - 1 ) - from bench to clinic [J]. Gan To Kagaku Ryoho,2001.
2Koizumi W. S - 1 plus cisplatin versus S - 1 alone for first - line treatment of advanced gastric cancer ( SPIRITS trial) :a phase. Ⅲ trial[J]. Lancel Oncol,2008.
3Takahashi I. S - 1 in the treatment of advanced and recurrent gastric cancercurrent state and future prospects [ J ]. GASTRIC CANCER,2003.
4Boku N. Chemotherapy for metastatic disease:review from JCOG trials [ J ]. International Journal of Clinical Oncology ,2008.
1Mufioz N, Francschi S.Epidemiology of gash'iv cancer and perspectives t pravension[J ].Salud Publica Mex, 1997,39 ( 4 ) : 318-330.
2Kamangar F, l)ores GM, Anderson WF.Palierns f cancer incidence, mortality, and prevalance actress five conlinenls: defining priorilies to reduce cancer disparities in diftrenl geographic regions of the world[J]. J Clin One,d,2006.24 ( 14): 2137 2150.
3Cunningham D, Starling N, Ra S, et al.Upper Gastrointeslinal Clinical Studies Group ff the Nati(mal Cancer Research Institute f the United Kingdom. Cape(,itabine and oxaliplatin tor adwmced esophagogastric cance[J].N Engl J Med,2008,358 ( 1 ) : 36 46.
4Kang YK. Kang WK, Shin DB, et al. Randomized phase lIl trial of capecitaline/cisplatin (XP) vs cm/inuous infusion of 5-FU/cisplatirt (FP) as fivsl-line therapy in patients with advanced gastric cancer: efficacy and safety results[J].J Clin Onvo1,2006,24 ( 18S ) : LBA4018.
5Dong Ningning, Jiang Wanrong. Li Huiqing, el al. Triweekly oxaliplatin plus oral capecitahine as flrst-tine chemotherapy in elderly patients with advan gastric cancer[J].Am J Clin Oncol, 2009,32 ( 6 ): 559-563.
6Koizumi W. Akiya T. Sat,. A, el aI.Phase I1 study of S-I as firsl-line Irealment ft." elderly patients ow, r 75 vears f age wish advanced gastric cancer: the rl'okyl Cooperative Oncol)gy Group study [J]. Cancer Chemother Pharmacol, 2010. 65 ( 6 ) : 1093-1099.
7Koizumi W, Narahara H, Har T, et al.tfandomised cmtrolled trial of S-1plus cisplatin versus S-1 alone for ill'st-line treatment t" advaned ga,+lri<. cancer (SPIRITS trial): a phase trial[J].Lancet Onul,2008,9 ( 3 3: 215 221.
8Tsuji A, Shima Y, Morita S, et al. Cmbination chemotherapy of S-I and low-dose twice-weekly cisplatin fir advanced and recurrent gastric' ean.er in an outpalienl setting: a retrospective study[J].Anticancer Res,2008,28 ( 2B): 1433-1438.
9Liu Bixia, Ying Jieer, l,uo Cong, et al. S-1 combined with oxaliplatin as first line chemotherapy for chinese advanced gastric cancer patients[J ]. ltepatogastrnenterolo,, 2012,59 ( 114 ) : 649-653.
10line JL, Kang YK, Kang HJ, et aI.A randomisml multieentre phase 11 trial of eapecitabine vs S-I as first-line treatment in ehlerly palienls with metastatic or recurrent unreseetable gastric cancer[J]. Br J Cancel', 2008, 99 ( 4 ) : 584-590.
